Don’t Assume MS Causes All Changes in Patients’ Disability
As the average age of people with multiple sclerosis (MS) increases, it becomes even more critical...
Read MoreMar 15, 2021
As the average age of people with multiple sclerosis (MS) increases, it becomes even more critical...
Read MoreMar 12, 2021
“Cognitive impairment (CI) occurs in 30% to 70% of people with multiple sclerosis (MS) and has a...
Read MoreMar 10, 2021
Low activity, high PM2.5 exposure increased diabetes risk in study Regular exercise appears to be...
Read MoreMar 9, 2021
Data indicate that overuse of antibiotics is a main driver of antibiotic resistance, with every...
Read MoreMar 9, 2021
Low activity, high PM2.5 exposure increased diabetes risk in study Regular exercise appears to be...
Read MoreMar 8, 2021
Management of chronic kidney disease (CKD) is a particular focus in East London, England, which...
Read MoreMar 5, 2021
Weight-teasing is a widespread phenomenon that begins in childhood and can promote the...
Read MoreMar 3, 2021
Postoperative pain has been shown in prior research to be a major challenge for patients with...
Read MoreMar 1, 2021
Research shows that the HPV vaccine can prevent more than 31,000 cancer cases each year in the...
Read MoreFeb 26, 2021
Obesity is a complex, multifactorial condition that is highly prevalent among adolescents. Eating...
Read MoreFeb 22, 2021
With long-term survivorship increasingly achievable among patients with cancer, many in this...
Read MoreFeb 19, 2021
In response to the COVID-19 pandemic, widespread adoption of remote care delivery for COPD...
Read MoreFeb 17, 2021
Research has shown that patients with COPD from different geographic regions in the United States...
Read MoreFeb 16, 2021
A retrospective analysis found that in patients with muscle-invasive bladder cancer (MIBC)...
Read MoreFeb 16, 2021
Radionuclide therapy directed towards prostate-specific membrane antigen (PSMA) demonstrated promising results in men with docetaxel-treated metastatic castration-resistant prostate cancer (mCRPC) [1]. A phase 2 trial compared...
Read MoreFeb 16, 2021
Tyrosine kinase inhibitor axitinib elicited a 31% response rate in a phase 2 clinical trial that...
Read MoreFeb 16, 2021
A phase 2 trial demonstrated encouraging outcomes from retroperitoneal lymph node dissection...
Read MoreFeb 16, 2021
A team of researchers reported that socioeconomic, racial/ethnic, and gender factors influence the...
Read MoreFeb 16, 2021
MRI is non-inferior to CT for the surveillance of stage 1 testicular seminoma. Over a 6-year...
Read MoreFeb 16, 2021
Of nearly 80,000,000 USD in funding for bladder cancer research between 2017 and 2019,...
Read More